OUR MANAGEMENT TEAM

Greg Guyatt, CA, CPA
CFO

Dr. Len Walt
Chief Medical Officer

Dr. Ilana Platt
VP, Innovation & Global Regulatory Affairs

Jeffrey Zietlow
VP, Innovation

Rob Schenkel
VP, IT

Michael Camplin
VP, Global Asset Management
& Expansion

BOARD OF DIRECTORS

Mark Litwin
Vice Chairman

  • President of Gencan Capital Inc., a CSE-listed corporation and Vice President of Mar-risa Holdings Inc., an investment and management holding company.
  • Previously President and a Director of Gencan’s predecessor corporations, which were listed on the TSX Venture Exchange and TSX.

Mitchell Sanders
Director

  • Senior Partner at Goldman, Spring, Kichler & Sanders LLP, an established boutique commercial law firm in Toronto.
  • Specializes in corporate finance, mergers and acquisitions, and securities law to mid-market clients in Canada and the US.
  • Serves on the board of numerous companies and not-for-profit entities.
  • Former member of the Small Business Advisory Committee to the Ontario Securities Commission and TEC, an international organization of CEO’s.

Mark Dawber, FCPA, FCA
Director

  • Mr. Dawber is a FCPA with significant public accounting experience having been an Audit Partner at Moore Stephens Hyde Houghton from 1971 until 1998 and BDO Canada LLP from 1999 to 2000.
  • He has extensive public company experience having served on public company boards for many years as an independent director, chair of audit committees and as a member of governance and compensation committees.
  • He has conducted numerous assignments for the Institute of Chartered Accountants of Ontario’s Professional Conduct Committee. 

Robert Marcovitch
Director

  • Mr. Marcovitch is a seasoned chief executive with substantial business experience, managing companies with in excess of $1 billion dollars in revenue.
  • Until recently, he was the President and CEO of K2 Sports, an international developer, manufacturer, marketer and distributor of winter sports equipment (and was previously with K2 from 1999 to 2011). His responsibilities included managing factories in Europe, the USA and Asia
  • He was previously the Chief Executive Officer at The Coleman Outdoor Company from 2011 until 2015, and prior to that, was Chief Executive Officer and President of Ride, Inc. from 1994 to 1999, which prior to its acquisition by K2 was a large publicly traded company.

Shawna Page
Director

  • Ms. Page brings years of experience in both the capital markets, as well as the consumer retail markets.
  • Ms. Page spent 10 years working at Merrill Lynch Canada, followed by 10 years at TD Securities where she was Managing Director and Chief of Staff. 
  • In 2007, Shawna launched a unique mass-channel brand of gender-specific and condition-specific products into the highly regulated nutraceutical industry across Canada, and later in various international markets, which she successfully exited in November 2016.

John Kaden
Director

  • Mr. Kaden is the Co-Founder, Managing Partner and Chief Investment Officer of Navy Capital Green Management LLC., a global investment firm based in New York City specializing in public and private investments in the emerging legal cannabis industry. 
  • Prior to this. Mr. Kaden was the co-Manager and Chief Investment Officer for Northwoods Capital Management LLC, a global hedge fund focused on the technology, media and telecom sector.
  • Before joining Northwoods, Mr. Kaden was the Founder and Managing Partner of Cynthion Partners, a global macro hedge fund, from 2006 through to the end of 2013. 
  • Mr. Kaden graduated Magna Cum Laude with an A.B. from Harvard University and a J.D. from Yale Law School.

Stan Abramowitz, CPA, CA
Secretary

  • More than 30 years of accounting practice and financial experience in Canada and South Africa.
  • CFO and Secretary of Forum, a Toronto based merchant banking group and Chief Financial Officer and a Director of Gencan Capital, a CSE-listed corporation.

CANNTRUST

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest